未登录

R

Ronald St-Louis

institut national de la santé et de la recherche médicale (inserm)

H指数:9

被引数:522

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dysregulation of CXCL1 Expression and Neutrophil Recruitment in Insulin Resistance and Diabetes-Related Periodontitis in Male Mice

IF7.5

2023-04-1415

OA

Endothelial Cells Induced Progenitors Into Brown Fat to Reduce Atherosclerosis

CIRCULATION RESEARCH

IF16.2

2022-07-0828

OA

Regeneration of glomerular metabolism and function by podocyte pyruvate kinase M2 in diabetic nephropathy

IF6.1

2022-03-0830

OA

Pyruvate Kinase M2 (PKM2) Enzymatic Activity Is Necessary to Improve Podocyte Mitochondrial Function and Glomerular Fuel Metabolism and Diabetic Nephropathy

IF7.5

2021-06-010

PRE

IGF-1 Receptors, Not Insulin Receptors, on Mesangial Cells Are Accelerating Mesangial Expansion and Albuminuria in Streptozotocin-Induced Diabetic Mice

IF7.5

2020-06-012

PRE

Targeted Deletion of Insulin Receptor in Vascular Smooth Muscle Cells Accelerated Thinning of Plaque Cap and Apoptosis and Atherosclerosis

IF7.5

2020-06-010

PRE

Characterization of Autoimmunity in the Acceleration of Atherosclerosis in Type 1 Diabetes

IF7.5

2020-06-010

PRE

Activation of Mitochondrial Activities by Pyruvate Kinase M2 (PKM2) in Podocytes Improved Glomerular Metabolism and Diabetic Nephropathy

IF7.5

2020-06-010

PRE

Reversal of Diabetic Nephropathy in T2D db/db Mouse Model by Systemic Pyruvate Kinase M2 (PKM2) Activation

IF7.5

2020-06-010

PRE

Insulin's Regulation of CXCL1 Expression Is Critical for Neutrophil Recruitments and the Development of Periodontitis and Poor Wound Healing in Diabetes

IF7.5

2019-06-011

PRE

ADA Presidents' Select Abstract: Pyruvate Kinase M2 Overexpression in Podocytes Ameliorates Nephropathy in Diabetic Mice

IF7.5

2019-06-010

PRE

Accelerating Atherosclerosis by Autoimmune Process in Nonobese Diabetic Mice Made ApoE Deficient by CRISPR/Cas9 Gene Editing

IF7.5

2019-06-010

PRE

Characterization of Glycolytic Enzymes and Pyruvate Kinase M2 in Type 1 and 2 Diabetic Nephropathy

IF16.6

2019-05-1078

OAAI

Endothelial/Nitric Oxide Regulation of Brown Adipose Tissue Activating Lipokine, 12, 13-diHOME and Its Antiatherogenic Actions

IF7.5

2018-07-010

PRE

Activation of PKM2 Protects against Diabetic Kidney Disease from Mice to Men

IF7.5

2018-07-011

PRE

Exogenous Insulin Infusion Can Decrease Atherosclerosis in Diabetic Rodents by Improving Lipids, Inflammation, and Endothelial Function

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

IF7.4

2018-01-0142

OAAI

High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes

CARDIOVASCULAR DIABETOLOGY

IF10.6

2017-09-1613

OAAI

Inflammatory Cytokines and Reactive Oxygen Species as Mediators of Chronic Kidney Disease-Related Vascular Calcification

AMERICAN JOURNAL OF HYPERTENSION

IF3.1

2014-11-27157

OAAI

Reactive oxygen species are physiological mediators of the noradrenergic signaling pathway in the mouse supraoptic nucleus

FREE RADICAL BIOLOGY AND MEDICINE

IF8.2

2014-06-0110

PREAI

Reactive Oxygen Species Are Required for the Hypothalamic Osmoregulatory Response

IF3.3

2012-03-0114

OAAI